Notice Information
Notice Title
Pandemic Resilience, Supply & R&D Agreement for mRNA vaccines
Notice Description
The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. The objective of security of supply in such circumstances is to be met by the construction of a mRNA manufacturing facility sited within the UK which will work alongside UK-based fill/finish providers to supply vaccines. In addition, the contract also includes certain commitments for the supplier to invest in R&D in the field of mRNA vaccines and therapeutics within the UK.
Lot Information
Lot 1
The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. Additional information: Contract value is being withheld due to commercial sensitivity (Reg 50(6)(b) and (c)). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:
(i) the supplier in its negotiations with other national governments
Procurement Information
The contract has been awarded under the exclusion in Regulation 15 (Defence and security) of the Public Contracts Regulations 2015. The contract is for protection of the essential security interests and resilience of future United Kingdom pandemic preparedness. The award follows the Authority's press announcement in June 2022 (https://www.gov.uk/government/news/moderna-to-open-vaccine-research-and-manufacturing-centre-in-uk) that it had entered into an agreement in principle with Moderna for the strategic partnership. The Authority is not obliged under the UK public procurement regulations to follow a statutory procurement process because Regulation 15(2)(a) (essential security interests of the UK) of the PCR 2015 applies. This notice is therefore being published on a voluntary basis. Nothing in this notice, nor in its publication, implies any intention or gives rise to an obligation to enter into a statutory procurement process under the UK public procurement regulations.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-039868
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/001501-2023
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
73 - Research and development services and related consultancy services
-
- CPV Codes
33651600 - Vaccines
73300000 - Design and execution of research and development
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 18 Jan 20233 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 20 Dec 20223 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- DEPARTMENT OF HEALTH AND SOCIAL CARE
- Contact Name
- Procurement Operations
- Contact Email
- procurement.operations@dhsc.gov.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- LONDON
- Postcode
- SW1H 0EU
- Post Town
- South West London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI3 Inner London - West
- Small Region (ITL 3)
- TLI35 Westminster and City of London
- Delivery Location
- Not specified
-
- Local Authority
- Westminster
- Electoral Ward
- St James's
- Westminster Constituency
- Cities of London and Westminster
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-039868-2023-01-18T10:35:47Z",
"date": "2023-01-18T10:35:47Z",
"ocid": "ocds-h6vhtk-039868",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-039868",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Pandemic Resilience, Supply & R&D Agreement for mRNA vaccines",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33651600",
"description": "Vaccines"
},
"mainProcurementCategory": "goods",
"description": "The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. The objective of security of supply in such circumstances is to be met by the construction of a mRNA manufacturing facility sited within the UK which will work alongside UK-based fill/finish providers to supply vaccines. In addition, the contract also includes certain commitments for the supplier to invest in R&D in the field of mRNA vaccines and therapeutics within the UK.",
"lots": [
{
"id": "1",
"description": "The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. Additional information: Contract value is being withheld due to commercial sensitivity (Reg 50(6)(b) and (c)). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:<br/><br/>(i) the supplier in its negotiations with other national governments",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "73300000",
"description": "Design and execution of research and development"
},
{
"scheme": "CPV",
"id": "33651600",
"description": "Vaccines"
}
],
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_OUTSIDE_SCOPE",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "The contract has been awarded under the exclusion in Regulation 15 (Defence and security) of the Public Contracts Regulations 2015. The contract is for protection of the essential security interests and resilience of future United Kingdom pandemic preparedness. The award follows the Authority's press announcement in June 2022 (https://www.gov.uk/government/news/moderna-to-open-vaccine-research-and-manufacturing-centre-in-uk) that it had entered into an agreement in principle with Moderna for the strategic partnership. The Authority is not obliged under the UK public procurement regulations to follow a statutory procurement process because Regulation 15(2)(a) (essential security interests of the UK) of the PCR 2015 applies. This notice is therefore being published on a voluntary basis. Nothing in this notice, nor in its publication, implies any intention or gives rise to an obligation to enter into a statutory procurement process under the UK public procurement regulations."
},
"awards": [
{
"id": "001501-2023-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-73048",
"name": "MODERNA BIOTECH UK LIMITED"
}
]
}
],
"parties": [
{
"id": "GB-FTS-43",
"name": "Department of Health and Social Care",
"identifier": {
"legalName": "Department of Health and Social Care"
},
"address": {
"streetAddress": "39 Victoria Street",
"locality": "London",
"region": "UKI32",
"postalCode": "SW1H 0EU",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Procurement Operations",
"email": "procurement.operations@dhsc.gov.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.gov.uk/government/organisations/department-of-health-and-social-care",
"buyerProfile": "https://www.gov.uk/government/organisations/department-of-health-and-social-care",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-73048",
"name": "MODERNA BIOTECH UK LIMITED",
"identifier": {
"legalName": "MODERNA BIOTECH UK LIMITED",
"id": "11990046"
},
"address": {
"streetAddress": "54 Portland Place, London, W1B 1DY",
"locality": "London",
"region": "UK",
"postalCode": "W1B 1DY",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-1661",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "The Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
}
}
],
"buyer": {
"id": "GB-FTS-43",
"name": "Department of Health and Social Care"
},
"contracts": [
{
"id": "001501-2023-1",
"awardID": "001501-2023-1",
"status": "active",
"dateSigned": "2022-12-20T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "3",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"id": "1",
"measure": "lowestValidBidValue",
"relatedLot": "1",
"value": 1,
"currency": "GBP"
},
{
"id": "2",
"measure": "highestValidBidValue",
"relatedLot": "1",
"value": 1,
"currency": "GBP"
}
]
},
"language": "en"
}